Form 4 for SNWV SANUWAVE Health, Inc.
Accepted 2025-04-07 00:00:00 ET · period of report 2017-12-14 · accession 0001437749-25-011179 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-04-07 | 2019-08-29 | SNWV | Stegagno Peter | COO | A - Grant | — | +2,026 | 2,032 | +33,767% | — |
| DM | 2025-04-07 | 2016-06-16+ | SNWV | Stegagno Peter | COO | A - Grant | $0.00 | +53.2K | 1,333 | New | $0 |
| DM | 2025-04-07 | 2019-01-23+ | SNWV | Stegagno Peter | COO | D - Sale to Iss | $0.00 | -4,937 | 0 | -100% | $0 |
| DM | 2025-04-07 | 2019-08-29 | SNWV | Stegagno Peter | COO | M - OptEx | $0.00 | -2,026 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2019-08-29 | A | A | 885 | — | 891 | D | — | — | (F1) On August 29, 2019, the reporting person exercised the Class N Warrants for 885 shares of common stock of Sanuwave Health, Inc. (the "Company") at an exercise price of $0.00029 per share. |
| 2 | Common | Common Stock | 2019-08-29 | A | A | 1,141 | — | 2,032 | D | — | — | (F2) On August 29, 2019, the reporting person exercised the Class O Warrants for 1,141 shares of the Company's common stock at an exercise price of $0.00029 per share. |
| 3 | Derivative | Stock Option (right to buy) | 2016-11-09 | A | A | 1,132 | $0.00 | 1,132 | D | $67.50 · — to 2026-11-09 | 1,132 Common Stock | (F9) Options were fully vested at the grant date. |
| 4 | Derivative | Stock Option (right to buy) | 2017-06-15 | A | A | 1,600 | $0.00 | 1,600 | D | $41.25 · — to 2027-06-15 | 1,600 Common Stock | (F9) Options were fully vested at the grant date. |
| 5 | Derivative | Stock Option (right to buy) | 2018-09-20 | A | A | 2,000 | $0.00 | 2,000 | D | $78.75 · — to 2028-09-20 | 2,000 Common Stock | (F9) Options were fully vested at the grant date. |
| 6 | Derivative | Stock Option (right to buy) | 2019-08-26 | A | A | 133 | $0.00 | 133 | D | $56.25 · — to 2029-08-26 | 133 Common Stock | (F9) Options were fully vested at the grant date. |
| 7 | Derivative | Stock Option (right to buy) | 2024-10-22 | A | A | 40,000 | $0.00 | 40,000 | D | $14.20 · — to 2034-10-22 | 40,000 Common Stock | (F10) Options will vest over a period of three years in 12 equal installments on each quarterly anniversary of the grant date. |
| 8 | Derivative | Class N Warrant (right to buy) | 2017-12-21 | A | A | 885 | $0.00 | 885 | D | $0.00 · 2017-12-21 to 2019-03-17 | 885 Common Stock | |
| 9 | Derivative | Class N Warrant (right to buy) | 2019-01-23 | D | D | 885 | $0.00 | 0 | D | $0.00 · 2017-12-21 to 2019-03-17 | 885 Common Stock | (F3) On January 23, 2019, the Company extended the expiration date of the Class N Warrants to May 1, 2019. |
| 10 | Derivative | Class N Warrant (right to buy) | 2019-01-23 | A | A | 885 | $0.00 | 885 | D | $0.00 · 2019-01-23 to 2019-05-01 | 885 Common Stock | (F3) On January 23, 2019, the Company extended the expiration date of the Class N Warrants to May 1, 2019. |
| 11 | Derivative | Class N Warrant (right to buy) | 2019-05-01 | D | D | 885 | $0.00 | 0 | D | $0.00 · 2019-01-23 to 2019-05-01 | 885 Common Stock | (F4) On May 1, 2019, the Company extended the expiration date of the Class N Warrants to June 28, 2019. |
| 12 | Derivative | Class N Warrant (right to buy) | 2019-05-01 | A | A | 885 | $0.00 | 885 | D | $0.00 · 2019-05-01 to 2019-06-28 | 885 Common Stock | (F4) On May 1, 2019, the Company extended the expiration date of the Class N Warrants to June 28, 2019. |
| 13 | Derivative | Class N Warrant (right to buy) | 2019-05-31 | D | D | 885 | $0.00 | 0 | D | $0.00 · 2019-05-01 to 2019-06-28 | 885 Common Stock | (F5) On May 31, 2019, the Company extended the expiration date of the Class N Warrants to September 3, 2019. |
| 14 | Derivative | Class N Warrant (right to buy) | 2019-05-31 | A | A | 885 | $0.00 | 885 | D | $0.00 · 2019-05-31 to 2019-09-03 | 885 Common Stock | (F5) On May 31, 2019, the Company extended the expiration date of the Class N Warrants to September 3, 2019. |
| 15 | Derivative | Class N Warrant (right to buy) | 2019-08-29 | M | D | 885 | $0.00 | 0 | D | $0.00 · 2019-05-31 to 2019-09-03 | 885 Common Stock | (F1) On August 29, 2019, the reporting person exercised the Class N Warrants for 885 shares of common stock of Sanuwave Health, Inc. (the "Company") at an exercise price of $0.00029 per share. |
| 16 | Derivative | Class O Warrant (right to buy) | 2017-12-11 | A | A | 1,141 | $0.00 | 1,141 | D | $0.00 · 2017-12-11 to 2019-03-17 | 1,141 Common Stock | (F6) On December 11, 2017, the reporting person received Class O Warrants exercisable for 1,141 shares of common stock at an exercise price of $0.00029 per share as compensation. |
| 17 | Derivative | Class O Warrant (right to buy) | 2019-03-01 | D | D | 1,141 | $0.00 | 0 | D | $0.00 · 2017-12-11 to 2019-03-17 | 1,141 Common Stock | (F7) On March 1, 2019, the Company extended the expiration date of the Class O Warrants to June 28, 2019. |
| 18 | Derivative | Class O Warrant (right to buy) | 2019-03-01 | A | A | 1,141 | $0.00 | 1,141 | D | $0.00 · 2019-03-01 to 2019-06-28 | 1,141 Common Stock | (F7) On March 1, 2019, the Company extended the expiration date of the Class O Warrants to June 28, 2019. |
| 19 | Derivative | Class O Warrant (right to buy) | 2019-05-31 | D | D | 1,141 | $0.00 | 0 | D | $0.00 · 2019-03-01 to 2019-06-28 | 1,141 Common Stock | (F8) On May 31, 2019, the Company extended the expiration date of the Class O Warrants to September 3, 2019. |
| 20 | Derivative | Class O Warrant (right to buy) | 2019-05-31 | A | A | 1,141 | $0.00 | 1,141 | D | $0.00 · 2019-05-31 to 2019-09-03 | 1,141 Common Stock | (F8) On May 31, 2019, the Company extended the expiration date of the Class O Warrants to September 3, 2019. |
| 21 | Derivative | Class O Warrant (right to buy) | 2019-08-29 | M | D | 1,141 | $0.00 | 0 | D | $0.00 · 2019-05-31 to 2019-09-03 | 1,141 Common Stock | (F2) On August 29, 2019, the reporting person exercised the Class O Warrants for 1,141 shares of the Company's common stock at an exercise price of $0.00029 per share. |
| 22 | Derivative | Stock Option (right to buy) | 2016-06-16 | A | A | 1,333 | $0.00 | 1,333 | D | $15.00 · — to 2026-06-16 | 1,333 Common Stock | (F9) Options were fully vested at the grant date. |